JP2023514725A5 - - Google Patents
Info
- Publication number
- JP2023514725A5 JP2023514725A5 JP2022550164A JP2022550164A JP2023514725A5 JP 2023514725 A5 JP2023514725 A5 JP 2023514725A5 JP 2022550164 A JP2022550164 A JP 2022550164A JP 2022550164 A JP2022550164 A JP 2022550164A JP 2023514725 A5 JP2023514725 A5 JP 2023514725A5
- Authority
- JP
- Japan
- Prior art keywords
- carboxamide
- oxy
- naphthyridine
- alkylene
- dimethoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980954P | 2020-02-24 | 2020-02-24 | |
| US62/980,954 | 2020-02-24 | ||
| US202063121418P | 2020-12-04 | 2020-12-04 | |
| US63/121,418 | 2020-12-04 | ||
| PCT/US2021/019294 WO2021173591A1 (en) | 2020-02-24 | 2021-02-23 | Compounds and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023514725A JP2023514725A (ja) | 2023-04-07 |
| JP2023514725A5 true JP2023514725A5 (https=) | 2024-03-01 |
Family
ID=74885066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022550164A Withdrawn JP2023514725A (ja) | 2020-02-24 | 2021-02-23 | 化合物および使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230151003A1 (https=) |
| EP (1) | EP4110779A1 (https=) |
| JP (1) | JP2023514725A (https=) |
| CN (1) | CN115605478A (https=) |
| AU (1) | AU2021226747A1 (https=) |
| CA (1) | CA3171473A1 (https=) |
| WO (1) | WO2021173591A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022551422A (ja) | 2019-09-26 | 2022-12-09 | エグゼリクシス， インコーポレイテッド | ピリドン化合物およびタンパク質キナーゼの調節における使用の方法 |
| CA3211063A1 (en) | 2021-02-19 | 2022-08-25 | Exelixis, Inc. | Pyridone compounds and methods of use |
| CN117343046A (zh) * | 2023-09-25 | 2024-01-05 | 辽宁大学 | 一种新型3-氧代-4-取代芳基-3,4-二氢吡嗪-2-甲酰胺类化合物及其应用 |
| CN118878515B (zh) * | 2024-06-19 | 2025-10-28 | 河北科技大学 | 一种取代苯胺嘧啶类化合物及其制备方法和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| JO2787B1 (en) * | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
| CN104072480B (zh) * | 2013-03-27 | 2016-12-28 | 沈阳药科大学 | 喹啉类化合物及其制备方法和应用 |
| TWI649308B (zh) * | 2013-07-24 | 2019-02-01 | 小野藥品工業股份有限公司 | 喹啉衍生物 |
| CN105461687B (zh) * | 2014-08-26 | 2020-06-19 | 北京京奉医药科技有限公司 | 含二氢哒嗪酮的喹啉类化合物及其用途 |
| ES2749726T3 (es) * | 2014-12-25 | 2020-03-23 | Ono Pharmaceutical Co | Derivado de quinolina |
| CN109896997A (zh) * | 2017-12-08 | 2019-06-18 | 中国药科大学 | N－酰基苯胺类c－Met激酶抑制剂的制备方法及其用途 |
| CN110330479A (zh) * | 2019-07-19 | 2019-10-15 | 南京华威医药科技集团有限公司 | 一种用作axl抑制剂的抗肿瘤化合物及其用途 |
-
2021
- 2021-02-23 JP JP2022550164A patent/JP2023514725A/ja not_active Withdrawn
- 2021-02-23 EP EP21712651.5A patent/EP4110779A1/en active Pending
- 2021-02-23 US US17/800,084 patent/US20230151003A1/en active Pending
- 2021-02-23 WO PCT/US2021/019294 patent/WO2021173591A1/en not_active Ceased
- 2021-02-23 AU AU2021226747A patent/AU2021226747A1/en not_active Abandoned
- 2021-02-23 CA CA3171473A patent/CA3171473A1/en active Pending
- 2021-02-23 CN CN202180030581.1A patent/CN115605478A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023514725A5 (https=) | ||
| JP2022551422A5 (https=) | ||
| JP2018080173A5 (https=) | ||
| JP2016164184A5 (https=) | ||
| JP2024513881A5 (https=) | ||
| KR100204433B1 (ko) | 4-아미노피리미딘 유도체 | |
| JP2014521701A5 (https=) | ||
| JP2014532070A5 (https=) | ||
| JP2021511360A5 (https=) | ||
| IL161337A (en) | N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase | |
| RU2008118156A (ru) | Производное триарилкарбоновой кислоты | |
| JP2014510132A5 (https=) | ||
| JP2010529991A5 (https=) | ||
| NZ601408A (en) | Novel 3-hydroxy-5-arylisothiazole derivative | |
| JP2015506355A5 (https=) | ||
| WO2016098005A1 (en) | Amido thiadiazole derivatives as nadph oxidase inhibitors | |
| JP2010515691A5 (https=) | ||
| JP2007519735A5 (https=) | ||
| CA2585053A1 (en) | Substituted n-acyl (hetero)aryl compounds as c-fms kinase inhibitors | |
| JP2007528379A5 (https=) | ||
| JP2007516173A5 (https=) | ||
| JP2019518036A5 (https=) | ||
| JP2012530765A5 (https=) | ||
| JP2020526547A5 (https=) | ||
| JP2013517279A5 (https=) |